ABX-196

DB16339InvestigationalSmall molecule

ABX-196 is under investigation in clinical trial NCT03897543 (ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma).

Chemical structure of ABX-196
Formula / weight
C50H98N2O9 · 871.339 g/mol (avg)
Code names
ABX-196 · PBS 96

Resolves to

Compound
UNIISOI87F7GN2CAS1161877-58-2
Structure
InChIKeyVITDDUXZOHEQMU-BYSUZVQFSA-NSMILESCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CNC(C)=O)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of ABX-196, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In